Publications by authors named "Tiandong Yan"

Claim this Profile
T
The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
Shiwei Deng, Tiandong Yan, Teodora Nikolova, Dominik Fuhrmann, Andrea Nemecek

Br J Pharmacol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms.
Shiwei Deng, Tiandong Yan, Cathleen Jendrny, Andrea Nemecek, Mladen Vincetic

BMC Cancer· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells.
Diana Marklein, Ulrike Graab, Ivonne Naumann, Tiandong Yan, Rosalie Ridzewski

PLoS One· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential roles of nitric oxide synthase isozymes in cardiotoxicity and mortality following chronic doxorubicin treatment in mice.
Shiwei Deng, Anke Kruger, Albrecht Schmidt, Annegret Metzger, Tiandong Yan

Naunyn Schmiedebergs Arch Pharmacol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topoisomerase II{alpha}-dependent and -independent apoptotic effects of dexrazoxane and doxorubicin.
Tiandong Yan, Shiwei Deng, Annegret Metzger, Ute Gödtel-Armbrust, Andrew C G Porter

Mol Cancer Ther· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis